Site identification and activation is an important milestone of clinical
trials and has a critical impact on subsequent trial timelines. Syncorp
provides an approach that is expedient and efficient to ensure the
highest quality and lowest risk to your trial. Our CRAs are skilled and
well-trained in clinical research to deliver the highest quality review of
data and effective interaction with study sites.
We utilize the most appropriate communication channels, dynamic patient education materials, loyalty programs, motivational tips, appreciation items related to the disease and reminders, we attract and retain broad pools of quality, prescreened patients.